First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

521 Reviews

Credit Rating - PHARMA TEST LIMITED

ANALYSIS
Credit Risk Update: PHARMA TEST LIMITED, C/O SIMPSON WREFORD AND PARNERS, SUFFOLK HOUSE, GEORGE STREET, CROYDON, SURREY, CR0 0YN. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 December 2022. The company was incorporated on 2 May 2001.

The accounts next due date is 30 September 2024. There are no mortgages.

The above was based on public record information as at 18 April 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 04209879
Date Incorporated: 2 May 2001
Date Latest Accounts: 31 December 2022
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 04209879
Annual Return: 2 May 2016
Registered Office: C/O SIMPSON WREFORD AND PARNERS, SUFFOLK HOUSE, GEORGE STREET, CROYDON, SURREY, CR0 0YN
SIC Code and Operations: 47789
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

PHARMA TEST LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 28 April 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
09019637 PHARMA TIMES MEDIA LIMITED Active
14373159 PHARMA TRADE LAB LIMITED Active - Proposal to Strike off
10714121 PHARMA TRADING LIMITED Active - Proposal to Strike off
09828175 PHARMA TRANSPORT LIMITED Active
04475559 PHARMA TRIAL LIMITED Active - Proposal to Strike off

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd